Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 128

Results For "president"

1680 News Found

Lupin Diagnostics opens first Reference Lab in East India
Diagnostic Center | March 10, 2022

Lupin Diagnostics opens first Reference Lab in East India

It is also setting up laboratories in West Bengal, Assam, Bihar, Jharkhand and Orissa to comprehensively cater to the East India region


OpenEye Scientific and Gaussian collaboration expands quantum chemistry calculations
Biotech | March 09, 2022

OpenEye Scientific and Gaussian collaboration expands quantum chemistry calculations

Using Orion, pharmaceutical and biotechnology companies, as well as any industrial researcher who wishes to perform electronic structure calculations, can gain access to elastic and flexible computational resources in the Cloud


Dr. Andreas Amrein joins Advanced Clinical to lead expansion in APAC, Europe and Canada
People | March 09, 2022

Dr. Andreas Amrein joins Advanced Clinical to lead expansion in APAC, Europe and Canada

With over 20 years of international leadership experience, Dr. Amrein has led many teams and organizations across over 30 geographies


AstraZeneca partners with Indian Society of Nephrology to promote kidney health
Public Health | March 09, 2022

AstraZeneca partners with Indian Society of Nephrology to promote kidney health

Under this year’s theme of ‘Kidney Health For All’, ISN along with AstraZeneca aims to generate large scale awareness and educate people about ways to improve kidney health


Novo Nordisk expands research collaboration for biologic medicines
Biotech | March 09, 2022

Novo Nordisk expands research collaboration for biologic medicines

This collaboration has resulted in several high-impact scientific publications describing breakthrough inventions, including the SOMA robotic pill, which has subsequently been licensed exclusively to Novo Nordisk for clinical development


Novartis, Voyager Therapeutics reach license deal for gene therapy vectors to combat neurological diseases
Biotech | March 09, 2022

Novartis, Voyager Therapeutics reach license deal for gene therapy vectors to combat neurological diseases

Agreement builds on previous Novartis success using emerging technologies to develop first-in-class gene therapies for neurological disorders


Industry upbeat on biopharma sector
News | March 08, 2022

Industry upbeat on biopharma sector

Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector


Merck’s KEYTRUDA demonstrates extended relief for patients with resected stage IIB and IIC melanoma
Biotech | March 08, 2022

Merck’s KEYTRUDA demonstrates extended relief for patients with resected stage IIB and IIC melanoma

New results build on previously reported significant recurrence-free survival (rfs) benefit seen in these patients


Moderna to set up first mRNA facility in Kenya
News | March 08, 2022

Moderna to set up first mRNA facility in Kenya

The company is investing up to US $ 500 million to produce up to 500 million doses each year for the African continent


Jardiance is first and only treatment approved in Europe for chronic heart failure
Drug Approval | March 07, 2022

Jardiance is first and only treatment approved in Europe for chronic heart failure

The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe